A Biological Quest Leads To A New Kind Of Breast Cancer Drug

The Food and Drug Administration has approved a drug that thwarts some enzymes breast cancer cells use to evade treatment with estrogen-blocking drugs.

» E-Mail This

—> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *